These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38211479)

  • 21. Parasitaemia and parasitic load are limited targets of the aetiological treatment to control the progression of cardiac fibrosis and chronic cardiomyopathy in Trypanosoma cruzi-infected dogs.
    Caldas IS; Menezes APJ; Diniz LF; Nascimento ÁFDSD; Novaes RD; Caldas S; Bahia MT
    Acta Trop; 2019 Jan; 189():30-38. PubMed ID: 30290285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of diminazene aceturate on renin-angiotensin system, infectious myocarditis and skeletal myositis in mice: An in vitro and in vivo study.
    Souza-Silva TG; Vilas-Boas DF; Gonçalves-Santos E; Mazzeti AL; Caldas IS; Gonçalves RV; Diniz LF; Novaes RD
    Life Sci; 2020 Sep; 257():118067. PubMed ID: 32652140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): study protocol for a randomised controlled trial.
    Villar JC; Herrera VM; Pérez Carreño JG; Váquiro Herrera E; Castellanos Domínguez YZ; Vásquez SM; Cucunubá ZM; Prado NG; Hernández Y
    Trials; 2019 Jul; 20(1):431. PubMed ID: 31307503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased intensity of inflammation in benznidazole-treated mice inoculated with Trypanosoma cruzi I stocks from Mexico and persistence of circulating parasites.
    Cruz-Zetina G; del Rio-Rodriguez R; Ramos-Ligonio A; López R; Monteon V
    Am J Trop Med Hyg; 2012 Oct; 87(4):671-4. PubMed ID: 22890036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydroxymethylnitrofurazone treatment in indeterminate form of chronic Chagas disease: Reduced intensity of tissue parasitism and inflammation-A histopathological study.
    Scarim CB; de Andrade CR; da Rosa JA; Dos Santos JL; Chin CM
    Int J Exp Pathol; 2018 Oct; 99(5):236-248. PubMed ID: 30320480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Schistosoma co-infection protects against brain pathology but does not prevent severe disease and death in a murine model of cerebral malaria.
    Bucher K; Dietz K; Lackner P; Pasche B; Fendel R; Mordmüller B; Ben-Smith A; Hoffmann WH
    Int J Parasitol; 2011 Jan; 41(1):21-31. PubMed ID: 20708623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological potential of new metronidazole/eugenol/dihydroeugenol hybrids against Trypanosoma cruzi in vitro and in vivo.
    Gonçalves-Santos E; Caldas IS; Fernandes VÂ; Franco LL; Pelozo MF; Feltrim F; Maciel JS; Machado JVC; Gonçalves RV; Novaes RD
    Int Immunopharmacol; 2023 Aug; 121():110416. PubMed ID: 37295025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination therapy using Pentostam and Praziquantel improves lesion healing and parasite resolution in BALB/c mice co-infected with Leishmania major and Schistosoma mansoni.
    Khayeka-Wandabwa C; Kutima H; Nyambati VC; Ingonga J; Oyoo-Okoth E; Karani L; Jumba B; Githuku K; Anjili CO
    Parasit Vectors; 2013 Aug; 6():244. PubMed ID: 23968249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of
    de Araújo MP; Burger E; Dias Novaes R; Ami Akatuti A; Rodrigues MÂ; Mendes ACSC; Bani GMC; Cardoso Santos E; Santos Mendonça AA; Martins Souza RL
    Biomed Res Int; 2019; 2019():8319465. PubMed ID: 31019973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Canova medication modifies parasitological parameters in mice infected with Trypanosoma cruzi.
    Pupulin AR; Marques-Araujo S; Toledo MJ; Gomes ML; Takejima E; Cuman RK; Bersani-Amado CA
    Exp Parasitol; 2010 Dec; 126(4):435-40. PubMed ID: 20433834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aspirin treatment of mice infected with Trypanosoma cruzi and implications for the pathogenesis of Chagas disease.
    Mukherjee S; Machado FS; Huang H; Oz HS; Jelicks LA; Prado CM; Koba W; Fine EJ; Zhao D; Factor SM; Collado JE; Weiss LM; Tanowitz HB; Ashton AW
    PLoS One; 2011 Feb; 6(2):e16959. PubMed ID: 21347238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antitrypanosomal Treatment with Benznidazole Is Superior to Posaconazole Regimens in Mouse Models of Chagas Disease.
    Khare S; Liu X; Stinson M; Rivera I; Groessl T; Tuntland T; Yeh V; Wen B; Molteni V; Glynne R; Supek F
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6385-94. PubMed ID: 26239982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pentamidine antagonizes the benznidazole's effect in vitro, and lacks of synergy in vivo: Implications about the polyamine transport as an anti-Trypanosoma cruzi target.
    Seguel V; Castro L; Reigada C; Cortes L; Díaz MV; Miranda MR; Pereira CA; Lapier M; Campos-Estrada C; Morello A; Kemmerling U; Maya JD; López-Muñoz R
    Exp Parasitol; 2016 Dec; 171():23-32. PubMed ID: 27729250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative PCR as a marker for preemptive therapy and its role in therapeutic control in Trypanosoma cruzi/HIV coinfection.
    Freitas VLT; Novaes CTG; Sartori AMC; Carvalho NB; Silva SCVD; Nakanishi ÉS; Salvador F; Castro CN; Bezerra RC; Westphalen EVN; Oliveira CMR; Busser FD; Ho YL; Buccheri R; Bonilla C; Shikanai-Yasuda MA
    PLoS Negl Trop Dis; 2024 Feb; 18(2):e0011961. PubMed ID: 38408095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pharmacological approach to reverse portal hypertention and hepatic schistosomal fibrosis in Egypt, control experimental study.
    Helmy AH; Abdel-Hady AA; el-Shanawany F; Hammam O; Abdel-Hady A
    J Egypt Soc Parasitol; 2005 Dec; 35(3):731-50. PubMed ID: 16333884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of benznidazole on infection course in mice experimentally infected with Trypanosoma cruzi I, II, and IV.
    Gruendling AP; Massago M; Teston AP; Monteiro WM; Kaneshima EN; Araújo SM; Gomes ML; Barbosa Md; Toledo MJ
    Am J Trop Med Hyg; 2015 Jun; 92(6):1178-89. PubMed ID: 25940197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concomitant Benznidazole and Suramin Chemotherapy in Mice Infected with a Virulent Strain of Trypanosoma cruzi.
    Santos EC; Novaes RD; Cupertino MC; Bastos DS; Klein RC; Silva EA; Fietto JL; Talvani A; Bahia MT; Oliveira LL
    Antimicrob Agents Chemother; 2015 Oct; 59(10):5999-6006. PubMed ID: 26169419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Doxycycline aggravates granulomatous inflammation and lung microstructural remodeling induced by Schistosoma mansoni infection.
    Santos MP; Gonçalves-Santos E; Gonçalves RV; Santos EC; Campos CC; Bastos DSS; Marques MJ; Souza RLM; Novaes RD
    Int Immunopharmacol; 2021 May; 94():107462. PubMed ID: 33611055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanoencapsulation of benznidazole in calcium carbonate increases its selectivity to Trypanosoma cruzi.
    Tessarolo LD; de Menezes RRPPB; Mello CP; Lima DB; Magalhães EP; Bezerra EM; Sales FAM; Barroso Neto IL; Oliveira MF; Dos Santos RP; Albuquerque EL; Freire VN; Martins AM
    Parasitology; 2018 Aug; 145(9):1191-1198. PubMed ID: 29642963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased susceptibility of mice infected with Schistosoma mansoni to recombinant vaccinia virus: association of viral persistence with egg granuloma formation.
    Actor JK; Marshall MA; Eltoum IA; Buller RM; Berzofsky JA; Sher A
    Eur J Immunol; 1994 Dec; 24(12):3050-6. PubMed ID: 7805733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.